Virology Research Today is a free monthly online journal that collates and summarizes the latest research about Virology, including details on viruses, pathology, classification, definitions.

Volume 4 (2008), Issue 7 (July)

1. Epidemiological and virological characterization of a large community-wide outbreak of hepatitis A in southern Italy.
   Epidemiol Infect, 136(8): 1027-34. [Abstract] [Full-text]
2. Adding interferon to lamivudine enhances the early virologic response and reversion of the precore mutation in difficult-to-treat HBV infection.
   J Gastroenterol, 43(6): 457-63. [Abstract] [Full-text]
3. Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy.
   Clin Infect Dis, 47(3): 421-4. [Abstract] [Full-text]
4. Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks.
   Hepatology, 48(1): 99-108. [Abstract] [Full-text]
5. Single-nucleotide polymorphisms in human beta-defensin-1 gene in Mozambican HIV-1-infected women and correlation with virologic parameters.
   AIDS, 22(12): 1515-7. [Abstract] [Full-text]
6. Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patients.
   AIDS, 22(12): 1513-5. [Abstract] [Full-text]
7. Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients.
   J Antimicrob Chemother, 62(2): 384-7. [Abstract] [Full-text]
8. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
   Eur J Gastroenterol Hepatol, 20(8): 778-83. [Abstract] [Full-text]
9. Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting.
   BMC Infect Dis, 8: 89. [Abstract] [Full-text]
10. Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological response.
    J Infect Dis, 198(4): 470-80. [Abstract] [Full-text]
11. Virological consequences of early events following cell-cell contact between human immunodeficiency virus type 1-infected and uninfected CD4+ cells.
    J Virol, 82(16): 7773-89. [Abstract] [Full-text]
12. Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey.
    Liver Int. [Abstract] [Full-text]
13. Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study.
    Liver Int. [Abstract] [Full-text]
14. Time to virological failure with atazanavir/ritonavir and lopinavir/ritonavir, with or without an H2-receptor blocker, not significantly different in HIV observational database study.
    Int J STD AIDS, 19(8): 561-2. [Abstract] [Full-text]

© 2005-2008 Virology Research Today. All Rights Reserved.